Form 4: BlackRock Increases Stake in BlackRock ESG Capital Allocation Term Trust

BlackRock, Inc. reports a purchase of 86,000 common shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at a weighted average price of $16.16 per share.

Summary

• On March 14, 2025, BlackRock, Inc. acquired 86,000 common shares of BlackRock ESG Capital Allocation Term Trust (ECAT).
• The shares were purchased at a weighted average price of $16.16, with individual prices ranging from $15.91 to $16.28 per share.
• Following the transaction, BlackRock, Inc. directly owns 668,800 common shares.
• Additionally, BlackRock Financial Management, Inc., a subsidiary of BlackRock, Inc., indirectly owns 5,000 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction disclosure. The increased stake could be interpreted as slightly positive, but without further context, it's difficult to gauge the overall impact.

Positives

• BlackRock's increased investment in ECAT could be seen as a positive signal, indicating confidence in the fund's performance or strategy.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders and large shareholders. BlackRock is a major player in the asset management industry, and its investment decisions are closely watched by the market.

Stakeholder Impact

• The increased stake by BlackRock could potentially increase investor confidence in the fund.

Key Dates